Synergetic action of atorvastatin and fluconazole against fluconazole-resistant Candida albicans in vitro and in a murine model for intra-abdominal Candidiasis / Ação sinérgica da atorvastatina e fluconazol contra Candida albicans resistente ao fluconazol in vitro e em um modelo murino contra Candidíase intra-abdominal

Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study

Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · see citing works

<i>Candida albicans</i> pathogenicity mechanisms

Mayer, F. L., Wilson, D., & Hube, B. (2013) · Virulence · doi:10.4161/viru.22913 · Cited by 1,848 · see citing works

Nonfilamentous C. albicans Mutants Are Avirulent

Lo, H.-J., Köhler, J. R., DiDomenico, B., Loebenberg, D., Cacciapuoti, A., & Fink, G. R. (1997) · Cell · doi:10.1016/s0092-8674(00)80358-x · Cited by 1,809 · see citing works

Invasive candidiasis

Pappas, P. G., Lionakis, M. S., Arendrup, M. C., Ostrosky-Zeichner, L., & Kullberg, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.26 · Cited by 1,636 · see citing works

Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D. N., Scheld, M., & Bartlett, J. G. (2006) · Clinical Infectious Diseases · doi:10.1086/499819 · Cited by 1,106 · see citing works

Growing and Analyzing Static Biofilms

Merritt, J. H., Kadouri, D. E., & O’Toole, G. A. (2005) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mc01b01s00 · Cited by 1,089 · see citing works

BiofilmsPreprint

López, D., Vlamakis, H. C., & Kolter, R. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000398 · Cited by 796 · see citing works

Epidemiology of Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991–2000

Marchetti, O., Bille, J., Fluckiger, U., Eggimann, P., Ruef, C., Garbino, J., Calandra, T., Glauser, M., Tauber, M. G., Pittet, D., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/380637 · Cited by 478 · see citing works

Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients

Bellmann, R., & Smuszkiewicz, P. (2017) · Infection · doi:10.1007/s15010-017-1042-z · Cited by 399 · see citing works

Atorvastatin reduces NF-κB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells

Ortego, M., Bustos, C., Hernández-Presa, M. Á., Tuñón, J., Díaz, C., Hernández, G., & Egido, J. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00193-8 · Cited by 339 · see citing works

Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle

Zore, G. B., Thakre, A. D., Jadhav, S., & Karuppayil, S. M. (2011) · Phytomedicine · doi:10.1016/j.phymed.2011.03.008 · Cited by 319 · see citing works

The chemokine receptors CXCR1/CXCR2 modulate antigen‐induced arthritis by regulating adhesion of neutrophils to the synovial microvasculature

Coelho, F. M., Pinho, V., Amaral, F. A., Sachs, D., Costa, V. V., Rodrigues, D. H., Vieira, A. T., Silva, T. A., Souza, D. G., Bertini, R., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23622 · Cited by 151 · see citing works

The Epidemiology of Intra-Abdominal Flora in Critically Ill Patients with Secondary and Tertiary Abdominal Sepsis

de Ruiter, J., Weel, J. F. L., Manusama, E. R., Kingma, W. P., & van der Voort, P. H. J. (2009) · Infection · doi:10.1007/s15010-009-8249-6 · Cited by 131 · see citing works

Protective mechanisms of atorvastatin against doxorubicin-induced hepato-renal toxicity

El‐Moselhy, M. A., & El‐Sheikh, A. A. K. (2013) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2013.09.001 · Cited by 115 · see citing works

Possible Inhibitory Molecular Mechanism of Farnesol on the Development of Fluconazole Resistance in Candida albicans Biofilm

Yu, L.-H., Wei, X., Ma, M., Chen, X., & Xu, S.-B. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05290-11 · Cited by 107 · see citing works

In vitro activity of fluvastatin, a cholesterol-lowering agent, and synergy with flucanazole and itraconazole against Candida species and Cryptococcus neoformans.

Chin, N. X., Weitzman, I., & Della-Latta, P. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.4.850 · Cited by 101 · see citing works

Simvastatin inhibits NF-κB signaling in intestinal epithelial cells and ameliorates acute murine colitis

Lee, J. Y., Kim, J. S., Kim, J. M., Kim, N., Jung, H. C., & Song, I. S. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.10.013 · Cited by 98 · see citing works

Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH

Ioannou, G. N., Rooyen, D. M. V., Savard, C. E., Haigh, W. G., Yeh, M. M., Teoh, N., & Farrell, G. C. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m053785 · Cited by 93 · see citing works

Pathogenic factors inCandidabiofilm-related infectious diseases

Hirota, K., Yumoto, H., Bayarmagnai, S., Matsuo, T., Ichikawa, T., & Miyake, Y. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13330 · Cited by 85 · see citing works

In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi: Synergistic interactions between statins and azoles

Nyilasi, I., Kocsubé, S., Krizsán, K., Galgóczy, L., Pesti, M., Papp, T., & Vágvölgyi, C. (2010) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2010.01972.x · Cited by 83 · see citing works

Are the Statins promising antifungal agents against invasive candidiasis?

Lima, W. G., Alves-Nascimento, L. A., Andrade, J. T., Vieira, L., de Azambuja Ribeiro, R. I. M., Thomé, R. G., dos Santos, H. B., Ferreira, J. M. S., & Soares, A. C. (2019) · Biomedicine &amp; Pharmacotherapy · doi:10.1016/j.biopha.2018.12.076 · Cited by 65 · see citing works

Design, synthesis, biological activity and structure-activity relationship studies of chalcone derivatives as potential anti-Candida agents

Andrade, J. T., Santos, F. R. D. S., Lima, W. G., de Sousa, C. D. F., Oliveira, L. S. F. M., Ribeiro, R. I. M. D. A., Gomes, A. J. P. S., Araújo, M. G. D. F., Villar, J. A. F. P., & Ferreira, J. M. S. (2018) · The Journal of Antibiotics · doi:10.1038/s41429-018-0048-9 · Cited by 57 · see citing works

Lovastatin synergizes with itraconazole against planktonic cells and biofilms of Candida albicans through the regulation on ergosterol biosynthesis pathway

Zhou, Y., Yang, H., Zhou, X., Luo, H., Tang, F., Yang, J., Alterovitz, G., Cheng, L., & Ren, B. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-8959-8 · Cited by 49 · see citing works

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Kim, K., Zilbermintz, L., & Martchenko, M. (2015) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-015-0090-4 · Cited by 48 · see citing works

Simvastatin inhibits planktonic cells and biofilms of Candida and Cryptococcus species

Brilhante, R. S. N., Caetano, É. P., de Oliveira, J. S., Castelo‐Branco, D. D. S. C. M., Souza, E. R. Y., de Alencar, L. P., Cordeiro, R. D. A., Bandeira, T. D. J. P. G., Sidrim, J. J. C., & Rocha, M. F. G. (2015) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2015.06.001 · Cited by 42 · see citing works

Pravastatin inhibits farnesol production in<i>Candida albicans</i>and improves survival in a mouse model of systemic candidiasis

Tashiro, M., Kimura, S., Tateda, K., Saga, T., Ohno, A., Ishii, Y., Izumikawa, K., Tashiro, T., Kohno, S., & Yamaguchi, K. (2012) · Medical Mycology · doi:10.3109/13693786.2011.610037 · Cited by 36 · see citing works

Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis

do Couto, F. M. M., do Nascimento, S. C., Pereira-Junior, S. F., da Silva, V. K. A., Leal, A. F. G., & Neves, R. P. (2016) · SpringerPlus · doi:10.1186/s40064-016-2130-8 · Cited by 25 · see citing works

Design, synthesis, and biodistribution studies of new analogues of marine alkaloids: Potent in vitro and in vivo fungicidal agents against Candida spp.

Andrade, J. T., Lima, W. G., Sousa, J. F., Saldanha, A. A., de Sá, N. P., Morais, F. B., Silva, M. K. P., Viana, G. H. R., Johann, S., Soares, A. C., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.113048 · Cited by 23 · see citing works

Species Distribution and Antifungal Susceptibility of Invasive Candidiasis: A 2016-2017 Multicenter Surveillance Study in Beijing, China

Guo, L., Yu, S.-Y., Xiao, M., Yang, C.-X., Bao, C., Yu, Y., Ye, L., Yang, Y., Zhang, G., Liu, J., et al. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s255843 · Cited by 21 · see citing works

Treatment with Atorvastatin Provides Additional Benefits to Imipenem in a Model of Gram-Negative Pneumonia Induced by Klebsiella pneumoniae in Mice

de Paula, T. P., Santos, P. C., Arifa, R. D. D. N., Vieira, A. T., Baltazar, L. D. M., Ávila, T. V., Fagundes, C. T., Garcia, Z. M., Lima, R. L., Teixeira, M. M., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00764-17 · Cited by 16 · see citing works

EPICO 3.0. Recommendations on invasive candidiasis in patients with complicated intra-abdominal infection and surgical patients with ICU extended stay

Maseda, E., Rodríguez, A. H., Aguilar, G., Pemán, J., Zaragoza, R., Ferrer, R., Llinares, P., & Grau, S. (2016) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2016.02.003 · Cited by 14 · see citing works

Efficacy of an oral and tropically stable lipid-based formulation of Amphotericin B (iCo-010) in an experimental mouse model of systemic candidiasis

Ibrahim, F., Sivak, O., Wasan, E. K., Bartlett, K. H., & Wasan, K. M. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-158 · Cited by 14 · see citing works

First report of polymyxin B activity in Klebsiella pneumoniae biofilm

Herrera, K. M. S., da Silva, F. K., de Oliveira, M. É., de Paiva, M. C., Soares, A. C., & Ferreira, J. M. S. (2019) · Journal of Chemotherapy · doi:10.1080/1120009x.2018.1558751 · Cited by 13 · see citing works

Elderly versus non-elderly patients with intra-abdominal candidiasis in the ICU

Dimopoulos, G., Matthaiou, D. K., Righi, E., Merelli, M., & Bassetti, M. (2017) · Minerva Anestesiologica · doi:10.23736/s0375-9393.17.11528-2 · Cited by 12 · see citing works

Freqüência e atividade enzimática de Candida albicans isoladas da mucosa bucal de crianças de uma creche da prefeitura de Fortaleza

Menezes, E. A., Cavalcante, M. D. S., Farias, R. B., Teixeira, A. B., Pinheiro, F. G., Bezerra, B. P., Torres, J. C. N., & Cunha, F. A. (2005) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442005000100004 · Cited by 10 · see citing works

Cholesterol-induced stimulation of postinflammatory liver fibrosis

Schwartz, Y. S., Dushkin, M. I., Комарова, Н. И., Воронцова, Е. В., & Kuznetsova, I. S. (2008) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-008-0175-6 · Cited by 10 · see citing works

DRUG REPURPOSING—Overcoming the translational hurdles to clinical use

Martin, J. H., & Bowden, N. A. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.548 · Cited by 6 · see citing works

Atorvastatin loaded elastasomes decorated with metal organic framework for treatment of vaginal candidiasis in wistar rats

Eliwa, A. S., Abdelkader, G., Abdel-Hakeem, M. A., Abdelmonem, R., El-Enin, H. A. A., Mohamed, G. G., & Gabre, R. M. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107625 · Cited by 10 · see citing works

Statins as Antifungal Agents: A Review on Drug Repurposing and Nanotechnology-Driven Delivery Strategies

e Silva, D. M., de Souza Lacerda, L., de Souza Andrioli, A., Braz, W. R., Campos, L. M., de Paiva, M. R. B., Pittella, F., Fabri, R. L., & Tavares, G. D. (2025) · Fundamental &amp; Clinical Pharmacology · doi:10.1111/fcp.70046 · Cited by 7 · see citing works

An in silico study involving Mangiferin, 7-Epiclusianone, Fukugetin, Lapachol, Plumbagin and Guttiferone-A against C. albicans proteins

Barros, A. G., de Araújo, L. P., da Silveira, N. J. F., & Santos, B. R. (2023) · Natural Resources for Human Health · doi:10.53365/nrfhh/158808 · Cited by 1 · see citing works

Effect of fluvastatin and pravastatin, HMG-CoA reductase inhibitors, on fluconazole activity against Candida albicans

NASH, J. D., BURGESS, D. S., & TALBERT, R. L. (2002) · Journal of Medical Microbiology · doi:10.1099/0022-1317-51-2-105 · Cited by 44 · see citing works

Are the Statins promising antifungal agents against invasive candidiasis?

Lima, W. G., Alves-Nascimento, L. A., Andrade, J. T., Vieira, L., de Azambuja Ribeiro, R. I. M., Thomé, R. G., dos Santos, H. B., Ferreira, J. M. S., & Soares, A. C. (2019) · Biomedicine &amp; Pharmacotherapy · doi:10.1016/j.biopha.2018.12.076 · Cited by 65 · see citing works

WITHDRAWN: In Vitro Study On The Potential Fungicidal Effects of Atorvastatin In Combination With Some Azole Drugs Against Multidrug Resistant Candida AlbicansPreprint

Mahmoud, D. E., Faraag, A. H. I., & El-Wafa, W. M. A. (2021) · Research Square · doi:10.21203/rs.3.rs-836090/v1 · Cited by 1 · see citing works

In vitro study on the potential fungicidal effects of atorvastatin in combination with some azole drugs against multidrug resistant Candida albicans

Mahmoud, D. E., Faraag, A. H. I., & Abu El-Wafa, W. M. (2021) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-021-03158-4 · Cited by 26 · see citing works

Antifungal effect of Atorvastatin against Candida species in comparison to Fluconazole and Nystatin

Nasr Esfahani, A., Golestannejad, Z., Khozeimeh, F., Dehghan, P., Maheronnaghsh, M., & Zarei, Z. (2019) · Medicine and Pharmacy Reports · doi:10.15386/mpr-1209 · Cited by 28 · see citing works